These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17085209)

  • 1. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
    Eskicorapci SY; Tuncay L
    J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Noburu Numao, Satoru Kawakami, Minato Yokoyama et al. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur urol 2007;52:1663-9.
    Boscolo-Berto R; Galfano A; Iafrate M
    Eur Urol; 2008 Aug; 54(2):469-70; author reply 471. PubMed ID: 18299171
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: The 20-core prostate biopsy protocol--a new gold standard?: V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod. J Urol 2008; 179: 504-507.
    Serefoglu EC; Ozdemir AT; Balbay MD
    J Urol; 2008 Nov; 180(5):2256-7. PubMed ID: 18804806
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
    Atmaca AF; Balbay MD
    J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance K. Fujika, P. Landis, B. K. McNeil and C. P. Pavlovich J Urol 2009; 182: 2664-2669.
    Atan A; Tuncel A
    J Urol; 2010 Jun; 183(6):2471-2. PubMed ID: 20416896
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
    Feldstein MS; Hentz JG
    J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. S. I. Berndt, J. L. Dodson, W. Y. Huang and K. K. Nicodemus, J Urol 2006; 175: 1613-1623.
    Rukin NJ; Luscombe CJ; Strange RC
    J Urol; 2007 Jan; 177(1):404. PubMed ID: 17162099
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
    Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
    Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006.
    Inman BA; Myers RP
    J Urol; 2006 Sep; 176(3):1252-3; author reply 1253. PubMed ID: 16890738
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
    Ng CF; Chan SY
    J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Best practice statement on cryosurgery for the treatment of localized prostate cancer R. J. Babaian, B. Donnelly, D. Bahn, J. G. Baust, M. Dineen, D. Ellis, A. Katz, L. Pisters, D. Rukstalis, K. Shinohara and J. B. Thrasher J Urol 2008; 180: 1993-2004.
    Gans W
    J Urol; 2009 May; 181(5):2388. PubMed ID: 19303086
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features: R. J. Cohen, B. A. Shannon, M. Phillips, R. E. Moorin, T. M. Wheeler and K. L. Garrett J Urol 2008; 179: 1762-1767.
    Mai KT; Veinot JP
    J Urol; 2008 Dec; 180(6):2714; author reply 214-5. PubMed ID: 18951578
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy: C. De Nunzio, A. Trucchi, R. Miano, A. Stoppacciaro, H. Fattahi, A. Cicione and A. Tubaro J Urol 2009; 181: 1069-1075.
    Brimo F; Vollmer RT; Bismar TA
    J Urol; 2009 Oct; 182(4):1653; author reply 1653-4. PubMed ID: 19683763
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Renal mass biopsy--a renaissance? B. R. Lane, M. K. Samplaski, B. R. Herts, M. Zhou, A. C. Novick and S. C. Campbell J Urol 2008; 179: 20-27.
    Park BK
    J Urol; 2009 May; 181(5):2386. PubMed ID: 19303098
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
    Labanaris AP; Kühn R; Zugor V
    J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted prostate biopsy using statistical image analysis.
    Zhan Y; Shen D; Zeng J; Sun L; Fichtinger G; Moul J; Davatzikos C
    IEEE Trans Med Imaging; 2007 Jun; 26(6):779-88. PubMed ID: 17679329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
    Calışkan S
    J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Improved accuracy in predicting the presence of gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Remzi M
    Eur Urol; 2007 Dec; 52(6):1668-9. PubMed ID: 17240039
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. I. F. San Francisco, M. M. Regan, W. C. DeWolf and A. F. Olumi, J Urol, 175: 1341-1346, 2006.
    Morales A
    J Urol; 2006 Dec; 176(6 Pt 1):2746; author reply 2746. PubMed ID: 17085212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.